Literature DB >> 11929866

Mer receptor tyrosine kinase signaling: prevention of apoptosis and alteration of cytoskeletal architecture without stimulation or proliferation.

Katherine L Guttridge1, J Christopher Luft, Thomas L Dawson, Eva Kozlowska, Nupam P Mahajan, Brian Varnum, H Shelton Earp.   

Abstract

Mer is a member of the Axl/Mer/Tyro3 receptor tyrosine kinase family, a family whose physiological function is not well defined. We constructed a Mer chimera using the epidermal growth factor receptor (EGFR) extracellular and transmembrane domains and the Mer cytoplasmic domain. Stable transfection of the Mer chimera into interleukin 3 (IL-3)-dependent murine 32D cells resulted in ligand-activable surface receptor that tyrosine autophosphorylated, stimulated intracellular signaling, and dramatically reduced apoptosis initiated by IL-3 withdrawal. However, unlike multiple other ectopically expressed receptor tyrosine kinases including full-length EGFR or an EGFR/Axl chimera, the Mer chimera did not stimulate proliferation. Moreover, and in contrast to EGFR, Mer chimera activation induced adherence and cell flattening in the normally suspension-growing 32D cells. The Mer chimera signal also blocked IL-3-dependent proliferation leading to G(1)/S arrest, dephosphorylation of retinoblastoma protein, and elongation of cellular processes. Unlike other agonists that lead to a slow (4-8 days) ligand-dependent differentiation of 32D cells, the combined Mer and IL-3 signal resulted in differentiated morphology and growth cessation in the first 24 h. Thus the Mer chimera blocks apoptosis without stimulating growth and produces cytoskeletal alterations; this outcome is clearly separable from the proliferative signal produced by most receptor tyrosine kinases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929866     DOI: 10.1074/jbc.M112086200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Mer tyrosine kinase (MerTK) promotes macrophage survival following exposure to oxidative stress.

Authors:  Adil Anwar; Amy K Keating; David Joung; Susan Sather; Grace K Kim; Kelly K Sawczyn; Luis Brandão; Peter M Henson; Douglas K Graham
Journal:  J Leukoc Biol       Date:  2009-04-22       Impact factor: 4.962

2.  Overexpression of apoptotic cell removal receptor MERTK in alveolar macrophages of cigarette smokers.

Authors:  Angeliki Kazeros; Ben-Gary Harvey; Brendan J Carolan; Holly Vanni; Anja Krause; Ronald G Crystal
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-27       Impact factor: 6.914

Review 3.  The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer.

Authors:  Douglas K Graham; Deborah DeRyckere; Kurtis D Davies; H Shelton Earp
Journal:  Nat Rev Cancer       Date:  2014-12       Impact factor: 60.716

4.  Analysis of dysregulation of immune system in pancreatic cancer based on gene expression profile.

Authors:  Baosheng Wang; Shaolong Sun; Zhen Liu
Journal:  Mol Biol Rep       Date:  2014-03-12       Impact factor: 2.316

5.  A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation.

Authors:  Susan Sather; Karla D Kenyon; Jerry B Lefkowitz; Xiayuan Liang; Brian C Varnum; Peter M Henson; Douglas K Graham
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

Review 6.  Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in development.

Authors:  Alisa B Lee-Sherick; Rachel M A Linger; Lia Gore; Amy K Keating; Douglas K Graham
Journal:  Br J Haematol       Date:  2010-08-31       Impact factor: 6.998

7.  Opposing Roles of Tyrosine Kinase Receptors Mer and Axl Determine Clinical Outcomes in Experimental Immune-Mediated Nephritis.

Authors:  Yuxuan Zhen; Stephen O Priest; Wen-Hai Shao
Journal:  J Immunol       Date:  2016-08-15       Impact factor: 5.422

8.  MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL.

Authors:  Kathryn A Tworkoski; James T Platt; Antonella Bacchiocchi; Marcus Bosenberg; Titus J Boggon; David F Stern
Journal:  Pigment Cell Melanoma Res       Date:  2013-05-21       Impact factor: 4.693

9.  The C-mer gene is induced by Epstein-Barr virus immediate-early protein BRLF1.

Authors:  Yuling Li; Nupam P Mahajan; Jennifer Webster-Cyriaque; Prasanna Bhende; Gregory K Hong; H Shelton Earp; Shannon Kenney
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 10.  TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.